Global Glucagon Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 94
Inquire Before Buying

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.

Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.

North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Glucagon market is valued at 491.6 million US$ in 2020 is expected to reach 747.6 million US$ by the end of 2026, growing at a CAGR of 6.1% during 2021-2026.

This report focuses on Glucagon volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Glucagon market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Glucagon market is segmented into

- Inject Glucagon

- Nasal Glucagon

Segment by Application

- Emergency Kits

- General Use

- Diagnostic & Motility

- Cardiogenic Shock

- Others

Global Glucagon Market: Regional Analysis

The Glucagon market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Glucagon market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Glucagon Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Glucagon market include:

- Novo Nordisk

- Eli Lilly

- Fresenius Kabi

- Torrent Labs

- Taj Pharmaceuticals

- Xeris Pharmaceuticals

Global Glucagon Market Research Report 2020

Table of Contents
1 Glucagon Market Overview
1.1 Product Overview and Scope of Glucagon
1.2 Glucagon Segment by Type
1.2.1 Global Glucagon Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Segment by Application
1.3.1 Glucagon Sales Comparison by Application: 2020 VS 2026
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size Estimates and Forecasts
1.4.1 Global Glucagon Revenue 2015-2026
1.4.2 Global Glucagon Sales 2015-2026
1.4.3 Glucagon Market Size by Region: 2020 Versus 2026
2 Global Glucagon Market Competition by Manufacturers
2.1 Global Glucagon Sales Market Share by Manufacturers (2015-2020)
2.2 Global Glucagon Revenue Share by Manufacturers (2015-2020)
2.3 Global Glucagon Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Glucagon Manufacturing Sites, Area Served, Product Type
2.5 Glucagon Market Competitive Situation and Trends
2.5.1 Glucagon Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Glucagon Players (Opinion Leaders)
3 Glucagon Retrospective Market Scenario by Region
3.1 Global Glucagon Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Glucagon Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Glucagon Market Facts & Figures by Country
3.3.1 North America Glucagon Sales by Country
3.3.2 North America Glucagon Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glucagon Market Facts & Figures by Country
3.4.1 Europe Glucagon Sales by Country
3.4.2 Europe Glucagon Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glucagon Market Facts & Figures by Region
3.5.1 Asia Pacific Glucagon Sales by Region
3.5.2 Asia Pacific Glucagon Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Glucagon Market Facts & Figures by Country
3.6.1 Latin America Glucagon Sales by Country
3.6.2 Latin America Glucagon Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Glucagon Market Facts & Figures by Country
3.7.1 Middle East and Africa Glucagon Sales by Country
3.7.2 Middle East and Africa Glucagon Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Glucagon Historic Market Analysis by Type
4.1 Global Glucagon Sales Market Share by Type (2015-2020)
4.2 Global Glucagon Revenue Market Share by Type (2015-2020)
4.3 Global Glucagon Price Market Share by Type (2015-2020)
4.4 Global Glucagon Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Glucagon Historic Market Analysis by Application
5.1 Global Glucagon Sales Market Share by Application (2015-2020)
5.2 Global Glucagon Revenue Market Share by Application (2015-2020)
5.3 Global Glucagon Price by Application (2015-2020)
6 Company Profiles and Key Figures in Glucagon Business
6.1 Novo Nordisk
6.1.1 Corporation Information
6.1.2 Novo Nordisk Description, Business Overview and Total Revenue
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Novo Nordisk Products Offered
6.1.5 Novo Nordisk Recent Development
6.2 Eli Lilly
6.2.1 Eli Lilly Glucagon Production Sites and Area Served
6.2.2 Eli Lilly Description, Business Overview and Total Revenue
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Eli Lilly Products Offered
6.2.5 Eli Lilly Recent Development
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Glucagon Production Sites and Area Served
6.3.2 Fresenius Kabi Description, Business Overview and Total Revenue
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Fresenius Kabi Products Offered
6.3.5 Fresenius Kabi Recent Development
6.4 Torrent Labs
6.4.1 Torrent Labs Glucagon Production Sites and Area Served
6.4.2 Torrent Labs Description, Business Overview and Total Revenue
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Torrent Labs Products Offered
6.4.5 Torrent Labs Recent Development
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Glucagon Production Sites and Area Served
6.5.2 Taj Pharmaceuticals Description, Business Overview and Total Revenue
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Taj Pharmaceuticals Products Offered
6.5.5 Taj Pharmaceuticals Recent Development
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Glucagon Production Sites and Area Served
6.6.2 Xeris Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Xeris Pharmaceuticals Products Offered
6.6.5 Xeris Pharmaceuticals Recent Development
7 Glucagon Manufacturing Cost Analysis
7.1 Glucagon Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glucagon
7.4 Glucagon Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glucagon Distributors List
8.3 Glucagon Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Glucagon Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Glucagon by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Glucagon by Type (2021-2026)
10.2 Glucagon Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Glucagon by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Glucagon by Application (2021-2026)
10.3 Glucagon Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glucagon by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Glucagon by Region (2021-2026)
10.4 North America Glucagon Estimates and Projections (2021-2026)
10.5 Europe Glucagon Estimates and Projections (2021-2026)
10.6 Asia Pacific Glucagon Estimates and Projections (2021-2026)
10.7 Latin America Glucagon Estimates and Projections (2021-2026)
10.8 Middle East and Africa Glucagon Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Glucagon Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Glucagon Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Glucagon Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Glucagon Manufacturers Covered in This Study
Table 5. Global Glucagon Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Glucagon Sales Share by Manufacturers (2015-2020)
Table 7. Global Glucagon Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Glucagon Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Glucagon Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Glucagon Sales Sites and Area Served
Table 11. Manufacturers Glucagon Product Types
Table 12. Global Glucagon Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Glucagon Players
Table 16. Global Glucagon Sales (K MT) by Region (2015-2020)
Table 17. Global Glucagon Sales Market Share by Region (2015-2020)
Table 18. Global Glucagon Revenue (Million US$) by Region (2015-2020)
Table 19. Global Glucagon Revenue Market Share by Region (2015-2020)
Table 20. North America Glucagon Sales by Country (2015-2020) (K MT)
Table 21. North America Glucagon Sales Market Share by Country (2015-2020)
Table 22. North America Glucagon Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Glucagon Revenue Market Share by Country (2015-2020)
Table 24. Europe Glucagon Sales by Country (2015-2020) (K MT)
Table 25. Europe Glucagon Sales Market Share by Country (2015-2020)
Table 26. Europe Glucagon Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Glucagon Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Glucagon Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Glucagon Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Glucagon Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Glucagon Revenue Market Share by Region (2015-2020)
Table 32. Latin America Glucagon Sales by Country (2015-2020) (K MT)
Table 33. Latin America Glucagon Sales Market Share by Country (2015-2020)
Table 34. Latin America Glucagon Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Glucagon Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Glucagon Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Glucagon Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Glucagon Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Glucagon Revenue Market Share by Country (2015-2020)
Table 40. Global Glucagon Sales (K MT) by Type (2015-2020)
Table 41. Global Glucagon Sales Share by Type (2015-2020)
Table 42. Global Glucagon Revenue (Million US$) by Type (2015-2020)
Table 43. Global Glucagon Revenue Share by Type (2015-2020)
Table 44. Global Glucagon Price (USD/MT) by Type (2015-2020)
Table 45. Global Glucagon Sales (K MT) by Application (2015-2020)
Table 46. Global Glucagon Sales Market Share by Application (2015-2020)
Table 47. Global Glucagon Sales Growth Rate by Application (2015-2020)
Table 48. Novo Nordisk Glucagon Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Novo Nordisk Main Product
Table 52. Novo Nordisk Recent Development
Table 53. Eli Lilly Glucagon Corporation Information
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Eli Lilly Main Product
Table 57. Eli Lilly Recent Development
Table 58. Fresenius Kabi Glucagon Corporation Information
Table 59. Fresenius Kabi Corporation Information
Table 60. Fresenius Kabi Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Fresenius Kabi Main Product
Table 62. Fresenius Kabi Recent Development
Table 63. Torrent Labs Glucagon Corporation Information
Table 64. Torrent Labs Corporation Information
Table 65. Torrent Labs Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Torrent Labs Main Product
Table 67. Torrent Labs Recent Development
Table 68. Taj Pharmaceuticals Glucagon Corporation Information
Table 69. Taj Pharmaceuticals Corporation Information
Table 70. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Taj Pharmaceuticals Main Product
Table 72. Taj Pharmaceuticals Recent Development
Table 73. Xeris Pharmaceuticals Glucagon Corporation Information
Table 74. Xeris Pharmaceuticals Corporation Information
Table 75. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Xeris Pharmaceuticals Main Product
Table 77. Xeris Pharmaceuticals Recent Development
Table 78. Sales Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Glucagon Distributors List
Table 81. Glucagon Customers List
Table 82. Market Key Trends
Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 84. Key Challenges
Table 85. Global Glucagon Sales (K MT) Forecast by Type (2021-2026)
Table 86. Global Glucagon Sales Market Share Forecast by Type (2021-2026)
Table 87. Global Glucagon Revenue (Million US$) Forecast by Type (2021-2026)
Table 88. Global Glucagon Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 89. Global Glucagon Sales (K MT) Forecast by Application (2021-2026)
Table 90. Global Glucagon Revenue (Million US$) Forecast by Application (2021-2026)
Table 91. Global Glucagon Sales (K MT) Forecast by Region (2021-2026)
Table 92. Global Glucagon Sales Market Share Forecast by Region (2021-2026)
Table 93. Global Glucagon Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Global Glucagon Revenue Market Share Forecast by Region (2021-2026)
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Glucagon
Figure 2. Global Glucagon Sales Market Share by Type: 2020 VS 2026
Figure 3. Inject Glucagon Product Picture
Figure 4. Nasal Glucagon Product Picture
Figure 5. Global Glucagon Consumption Market Share by Application: 2020 VS 2026
Figure 6. Emergency Kits
Figure 7. General Use
Figure 8. Diagnostic & Motility
Figure 9. Cardiogenic Shock
Figure 10. Others
Figure 11. Global Glucagon Market Size 2015-2026 (US$ Million)
Figure 12. Global Glucagon Sales Capacity (K MT) (2015-2026)
Figure 13. Global Glucagon Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Glucagon Sales Share by Manufacturers in 2020
Figure 15. Global Glucagon Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Glucagon Revenue in 2019
Figure 17. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Glucagon Sales Market Share by Region (2015-2020)
Figure 19. Global Glucagon Sales Market Share by Region in 2019
Figure 20. Global Glucagon Revenue Market Share by Region (2015-2020)
Figure 21. Global Glucagon Revenue Market Share by Region in 2019
Figure 22. North America Glucagon Sales Market Share by Country in 2019
Figure 23. North America Glucagon Revenue Market Share by Country in 2019
Figure 24. U.S. Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 25. U.S. Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 27. Canada Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Glucagon Sales Market Share by Country in 2019
Figure 29. Europe Glucagon Revenue Market Share by Country in 2019
Figure 30. Germany Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 31. Germany Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 39. Russia Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Glucagon Sales Market Share by Region in 2019
Figure 41. Asia Pacific Glucagon Revenue Market Share by Region in 2019
Figure 42. China Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 43. China Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 45. Japan Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 49. India Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 51. Australia Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 53. Taiwan Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 55. Indonesia Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 57. Thailand Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 59. Malaysia Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 61. Philippines Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 63. Vietnam Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Glucagon Sales Market Share by Country in 2019
Figure 65. Latin America Glucagon Revenue Market Share by Country in 2019
Figure 66. Mexico Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 67. Mexico Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 69. Brazil Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Glucagon Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Glucagon Revenue Market Share by Country in 2019
Figure 74. Turkey Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 75. Turkey Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 77. Saudi Arabia Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Glucagon Sales Growth Rate (2015-2020) (K MT)
Figure 79. U.A.E Glucagon Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Glucagon by Type (2015-2020)
Figure 81. Sales Market Share of Glucagon by Type in 2019
Figure 82. Revenue Share of Glucagon by Type (2015-2020)
Figure 83. Revenue Market Share of Glucagon by Type in 2019
Figure 84. Global Glucagon Sales Growth by Type (2015-2020) (K MT)
Figure 85. Global Glucagon Sales Market Share by Application (2015-2020)
Figure 86. Global Glucagon Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Glucagon by Application (2015-2020)
Figure 88. Global Revenue Share of Glucagon by Application in 2020
Figure 89. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Torrent Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Xeris Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Price Trend of Key Raw Materials
Figure 96. Manufacturing Cost Structure of Glucagon
Figure 97. Manufacturing Process Analysis of Glucagon
Figure 98. Glucagon Industrial Chain Analysis
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Porter's Five Forces Analysis
Figure 102. North America Glucagon Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 103. North America Glucagon Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Glucagon Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Glucagon Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Glucagon Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Glucagon Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Glucagon Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Glucagon Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Glucagon Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Glucagon Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs